Syngenta AG Chief Executive Officer Erik Fyrwald sees the imminent $43 billion Chinese takeover of the Swiss company as a timely moment to gain a powerful benefactor just as a host of antitrust reviews triggers an abundance of acquisition opportunities.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com